Pharmabiz22m
Kelun-Biotech’s TROP2 ADC sacituzumab tirumotecan receives China NMPA marketing approval for 2L+ advanced or metastatic TNBC
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd., a holding subsidiary of Kelun Pharmaceutical, which focuses on the R&D, manufacturing, commercialization and global collaboration of innovative ...
Pharmabiz1h
Novartis Kisqali receives European approval in a broad population of patients with HR+/HER2- early breast cancer at high risk of recurrence
Novartis Kisqali receives European approval in a broad population of patients with HR+/HER2- early breast cancer at high risk of recurrence: Basel Thursday, November 28, 2024, 09: ...
Pharmabiz2h
PCI asks all pharmacy institutions to appoint nodal officers related to award of scholarship
PCI asks all pharmacy institutions to appoint nodal officers related to award of scholarship: Gireesh Babu, New Delhi ...
Pharmabiz2h
DGFT updates import policy for pharma in sync with Finance Act 2024
DGFT updates import policy for pharma in sync with Finance Act 2024: Shardul Nautiyal, Mumbai Thursday, November 28, 2024, 08:00 Hrs [IST] The Union ministry of commerce & industr ...
Pharmabiz2h
Indian healthcare industry turns to technology to address fragmented payment landscape
Indian healthcare industry turns to technology to address fragmented payment landscape: Nandita Vijayasimha, Bengaluru Thursday, November 28, 2024, 08:00 Hrs [IST] Indian healthca ...
Pharmabiz2h
BIS prioritises standard development for 214 critical medical devices by December 2025
BIS prioritises standard development for 214 critical medical devices by December 2025: Our Bureau, New Delhi Thursday, November 28, 2024, 08:00 Hrs [IST] The Bureau of Indian Sta ...
Pharmabiz10h
Cassava Sciences’ ReThink-ALZ phase 3 study of simufilam in mild-to-moderate AD fails to meet co-primary endpoints
Cassava Sciences, Inc., a clinical-stage biotechnology company focused on developing a novel, investigational treatment for Alzheimer’s disease (AD) dementia, announced that the topline results from ...
Pharmabiz17h
BioNxt reports expansion of its next-generation product pipeline with innovative solutions for autoimmune diseases and longevity
BioNxt reports expansion of its next-generation product pipeline with innovative solutions for autoimmune diseases and longevity: Vancouver, BC Wednesday, November 27, 2024, 17:00 ...
Pharmabiz18h
Abbott announces first step toward its software-guided balloon-expandable TAVI System to treat aortic stenosis
Abbott announces first step toward its software-guided balloon-expandable TAVI System to treat aortic stenosis: Abbott Park, Illinois Wednesday, November 27, 2024, 16:00 Hrs [IST] ...
Pharmabiz19h
J INTS BIO, MD Anderson develop ‘JIN-001' for brain tumour treatment to enhance radiation and chemotherapy efficacy
J INTS BIO, MD Anderson develop ‘JIN-001' for brain tumour treatment to enhance radiation and chemotherapy efficacy: Seoul, South Korea Wednesday, November 27, 2024, 15:00 Hrs [ ...
Pharmabiz19h
Johnson & Johnson unveils ‘India Detects to Defeat’ initiative to urge for early lung cancer detection and testing
Johnson & Johnson unveils ‘India Detects to Defeat’ initiative to urge for early lung cancer detection and testing: Our Bureau, Mumbai Wednesday, November 27, 2024, 14:45 Hrs ...
Pharmabiz19h
Centrum addresses growing joint health concerns with launch of Centrum Joint & Mobility Capsule in India
Centrum addresses growing joint health concerns with launch of Centrum Joint & Mobility Capsule in India: Our Bureau, Mumbai Wednesday, November 27, 2024, 14:30 Hrs [IST] Centrum, ...